CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients
Authors:
Open Access
- 13 January 2009
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (2) , 360-365
Abstract
Patients with UICC stage II colorectal cancer (CRC) have a risk of approximately 20% to develop disease recurrence after tumour resection. The presence and significance of micrometastases for locoregional recurrence in these patients lacking histopathological lymph node involvement on routine stained HE sections is undefined. Oestrogen receptor (ER) promoter methylation has earlier been identified in CRC. Therefore, we evaluated the methylation status of the ER promoter in lymph nodes from 49 patients with CRC UICC stage I and II as a molecular marker of micrometastases and predictor of local recurrence. DNA from 574 paraffin-embedded lymph nodes was isolated and treated with bisulphite. For the detection of methylated ER promoter sequences, quantitative real-time methylation-specific PCR was used. Of the 49 patients tested, 15 (31%) had ER methylation-positive lymph nodes. Thirteen of those (86%) remained disease free and two (14%) developed local recurrence. In the resected lymph nodes of 34 of the 49 patients (69%), no ER promoter methylation could be detected and none of these patients experienced a local relapse. The methylation status of the ER promoter in lymph nodes of UICC stage I and II CRC patients may be a useful marker for the identification of patients at a high risk for local recurrence.Keywords
This publication has 39 references indexed in Scilit:
- Quantitative Analysis of Methylation of Genomic Loci in Early-Stage Rectal Cancer Predicts Distant RecurrenceJournal of Clinical Oncology, 2008
- Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerProceedings of the National Academy of Sciences, 2007
- Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative StudyJournal of Clinical Oncology, 2007
- Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCRBritish Journal of Cancer, 2006
- Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancerJournal of Surgical Oncology, 2005
- Quantification of Colorectal Cancer Micrometastases in Lymph Nodes by Nested and Real-Time Reverse Transcriptase-PCR Analysis for Carcinoembryonic AntigenClinical Cancer Research, 2004
- Prognostic Significance of Cytokeratin-20 Reverse Transcriptase Polymerase Chain Reaction in Lymph Nodes of Node-Negative Colorectal Cancer PatientsJournal of Clinical Oncology, 2002
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994